B. Lynn Allen-Hoffman High School Attended: Roberts-Thawville B. Lynn Allen-Hoffman graduated from Roberts-Thawville High School in 1970. After graduating high school she went on to attend the University of Illinois where she earned a Bachelor’s of Science degree from the College of Liberal Arts and Sciences. From there Lynn went on to Cornell University and the Massachusetts Institute of Technology where she earned a PhD in Toxicology and Biochemistry in 1981. After graduating with her PhD, Dr. Allen-Hoffman went on to work at the Harvard School of Medicine and then the University of Wisconsin School of Medicine and Public Health, where her research and career began to flourish. Dr. Allen-Hoffman founded and currently serves as the Chief Executive Officer, the Chief Science Officer and the Chair of the Board of Directors for Stratatech Corporation, which is a regenerative medicine company focused on the commercialization of unique, proprietary skin regeneration and repair products for therapeutic use. The company was founded in 2000 to commercialize NIKS® cells, which is a human keratinocyte cell line that produces living tissue nearly identical to native human skin. The company uses this progenitor cell line to create a portfolio of therapeutic products such as StrataGraft®, which is used to treat severe burns, and ExpressGraft™ skin tissues, which are genetically enhanced to produce elevated levels of natural, human wound-healing factors that fight infection, improve blood flow and increase the rate of healing. Among her many accomplishments Dr. Allen-Hoffman won the March of Dimes Basil O’Connor Scholar Research Award in 1986, the Wisconsin Innovation Award in 2003, the Harold P. Rusch Award in 2005, the TEMPO Leader by Example Award in 2006 and in 2013 Stratatech Corporation was awarded a $47.2 million contract from the Department of Health and Human Services, Office of Preparedness and Response, Biomedical Advanced Research and Development Authority for advanced development and clinical investigation of the company’s StrataGraft® skin tissue for use in treatment of burn victims in the event of a domestic terrorist attack.